Topic: Adverse Events with Inert Substances

Adverse Events Occurring for Placebo Groups in Cancer Trials

Diego Enrico, MD of the Argentine Association of Clinical Oncology, Buenos Aires, Argentina and colleagues examined the incidence of placebo […]